Free Trial
OTCMKTS:CURLF

Curaleaf Q4 2025 Earnings Results & Report

Curaleaf logo
$9.25 -0.14 (-1.49%)
As of 03:59 PM Eastern

Curaleaf beat analyst expectations on both earnings and revenue in its Q4 2025 results, released February 26, 2026. The company reported EPS of -$0.15 versus the -$0.24 consensus estimate, while revenue of $333.07 million topped the $328.70 million estimate by $4.37 million.

Earnings Announcement Details

Quarter
Q4 2025
Time
After Market Closes

Curaleaf EPS Results

Actual EPS
-$0.15
Consensus EPS
-$0.24
Beat/Miss
Beat by +$0.09
One Year Ago EPS
N/A
EPS Beat Rate
6 of last 8 quarters

Curaleaf Revenue Results

Actual Revenue
$333.07 million
Expected Revenue
$328.70 million
Beat/Miss
Beat by +$4.37 million
YoY Revenue Growth
N/A

Conference Call Resources

Curaleaf Q4 2025 Earnings FAQ

Curaleaf (OTCMKTS:CURLF) reported earnings of -$0.15 per share for Q4 2025, beating the consensus estimate of -$0.24. The report was announced on Thursday, February 26, 2026.

Curaleaf reported revenue of $333.07 million for Q4 2025, against a consensus estimate of $328.70 million.

Curaleaf Earnings Headlines

Trump To Relaunch USD?
President Trump's summit with Xi Jinping drew headlines for tariffs and trade truces, but the real story may be a bid to reset the US dollar. Porter Stansberry says the meeting, attended by figures like Elon Musk, Jensen Huang and Larry Fink, connects to a 13-nation pact designed to cut China out of a massive investment wave.tc pixel
Curaleaf Files Update to Offering Circular
Curaleaf raises Aurora Cannabis offer by 25%
Curaleaf Enhances Offer to Acquire Aurora Cannabis
See More Curaleaf Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Curaleaf? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Curaleaf and other key companies, straight to your email.

About Curaleaf

Curaleaf (OTCMKTS:CURLF) is a cannabis company that cultivates, processes, manufactures and sells cannabis products. Through its retail dispensaries and wholesale operations, the company offers flower, pre-rolls, vaporizers, edibles, concentrates, tinctures and other cannabis-derived products for medical and adult-use markets, where permitted by law.

Curaleaf markets products under brands that include Curaleaf, Select and Grassroots. Its business is primarily focused on the United States, where it operates a network of cultivation and processing facilities, dispensaries and distribution operations across multiple state-regulated cannabis markets. The company has also pursued international opportunities through its European cannabis operations.

Founded in 2010, Curaleaf has expanded through organic growth and acquisitions to become one of the larger cannabis operators in North America. The company is led by Executive Chairman Boris Jordan and Chief Executive Officer Matt Darin.

View Curaleaf Profile